CareDx Presents 50+ Abstracts at ISHLT 2026 Annual Meeting
CareDx, Inc. announces its participation in the ISHLT 2026 Annual Meeting, where it will present over 50 abstracts, including 16 oral presentations, showcasing advancements in precision medicine for transplant patients.
BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced its participation at the International Society of Heart and Lung Transplantation (ISHLT) 2026 Annual Meeting, taking place April 22–25 in Toronto, Canada. The real-world clinical use and scient